Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001193805-14-000002)

Filing Details

Accession Number:: 0001193805-14-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-02 06:41:04
Reporting Period:: 2013-12-16

Filing Date:: 2014-01-02
Accepted Time:: 2014-01-02 06:41:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438533	Retrophin Inc.	RTRX	Pharmaceutical Preparations (2834)	262383102

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1525354	Martin Shkreli	C/O Retrophin, Inc. 777 Third Avenue, 22Nd Floor New York NY 10017	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-31	150,000	$7.00	2,816,246	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.0001 Per Share	Employee Stock Option (Right to Buy)	Acquisiton	2013-12-16	1,080,000	$0.00	1,080,000	$7.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,080,000		2023-12-16	No	4	A	Direct

Footnotes

In accordance with the terms of privately-negotiated transactions, the Reporting Person is required to pay the Sellers of such shares $7.00 per share of the Issuer's common stock, subject to adjustments under certain circumstances.
The option vests in twelve equal installments on the last day of each calendar quarter beginning on December 31, 2013.